Can a smart glucose monitor keep blood sugar in check after hospital leave?
NCT ID NCT07414277
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin after leaving the hospital. One group uses a continuous glucose monitor (CGM) that shows real-time levels and trends, while the other group uses traditional fingerstick tests. The goal is to see if CGM leads to better blood sugar control over 12 weeks, with follow-up at 24 weeks. 160 adults aged 18–80 with type 2 diabetes and an HbA1c between 8% and 13% are being recruited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Real-Time Continuous Glucose Monitoring (RT-CGM) device
What this could lead to
If it works, this could show that using a continuous glucose monitor helps people with type 2 diabetes manage their blood sugar better after leaving the hospital.
What could go wrong
This is a relatively small, early-stage trial (160 people) comparing two monitoring methods, not testing a new drug or cure. The results may not apply to all patients, and the device itself does not treat diabetes—it only tracks glucose levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai 6th People's Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai 7th People's Hospital
RECRUITINGShanghai, 200137, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Fengxian District Central Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai General Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••